Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Randomized Controlled Prospective Single-center Feasibility Study of Rheopheresis for Raynaud's Syndrome and Digital Ulcers in Systemic Sclerosis

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05204784
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:44.691472+00:00
Published At
2022-03-23T00:00:00+00:00
Record Updated At
2022-03-23
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Systemic Sclerosis", "Raynaud Phenomenon", "Digital Ulcer", "Scleroderma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2022-03-23"
protocolSection.identificationModule.nctId
"NCT05204784"
protocolSection.identificationModule.officialTitle
"A Randomized Controlled Prospective Single-center Feasibility Study of Rheopheresis for Raynaud\u0027s Syndrome and Digital Ulcers in Systemic Sclerosis"
protocolSection.statusModule.overallStatus
"UNKNOWN"
protocolSection.designModule.phases
["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Systemic Sclerosis (protocolSection.conditionsModule.conditions)
  • Raynaud Phenomenon (protocolSection.conditionsModule.conditions)
  • Digital Ulcer (protocolSection.conditionsModule.conditions)
  • Scleroderma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.